Related Experiment Video
Updated: Jul 17, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Breast cancer proteomics: clinical perspectives
Thomas Y K Lau1, Darran P O'Connor, Donal J Brennan
1UCD Conway Institute, UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin 4, Ireland.
Expert Opinion on Biological Therapy
|January 26, 2007
Summary
Breast cancer research is identifying new biomarkers and drug targets. Proteomics analyzes the breast cancer proteome to improve detection and treatment strategies.
Area of Science:
- Oncology
- Biochemistry
- Proteomics
Background:
- Breast cancer is a leading cause of cancer death in women globally.
- Improved detection and treatment are critical for patient outcomes.
- Identifying novel biomarkers and drug targets is a major research focus.
Purpose of the Study:
- To review the progress of breast cancer proteomics.
- To highlight the potential clinical applications of proteomics in breast cancer.
Main Methods:
- Review of current scientific literature on breast cancer proteomics.
- Analysis of proteomic techniques and their application to breast cancer research.
Main Results:
- Proteomics offers advanced methods for analyzing the complex breast cancer proteome.
- Significant advancements have been made in applying proteomics to identify biomarkers and drug targets.
Conclusions:
- Breast cancer proteomics has progressed significantly.
- Proteomics holds substantial promise for improving breast cancer detection and treatment in clinical settings.
